“Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone” (2020) SKIN The Journal of Cutaneous Medicine, 4(3), pp. 288–291. doi:10.25251/skin.4.3.15.